July 22nd, 2020
A versatile vessel for next-gen therapeutics
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Therapeutics
May 7th, 2019
Harvard University, Broad Institute extend CRISPR human therapeutics license to Verve Therapeutics
Agreement enables development of genome-based therapies to protect against heart disease in adults
March 13th, 2019
Harvard and Deerfield establish Lab1636, a major translational research alliance
Deerfield commits $100M to inject fuel into translational life science research at Harvard
October 19th, 2017
Heading off the post-antibiotic age
Second annual Harvard FUSION symposium explores the Science and Business of Combating Antibiotic Resistance
August 24th, 2016
An agent of demise
Harvard scientists identify spark plug that ignites nerve cell damage in Lou Gehrig’s disease
